Epoetin alfa (Eprex®) - For the treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status
All Wales Medicines Strategy Group (AWMSG)
Record ID 32012000483
English
Details
Project Status:
Completed
Year Published:
2003
URL for published report:
http://www.wales.nhs.uk/sites3/docmetadata.cfm?orgid=371&id=176046&pid=24773
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Wales, United Kingdom
MeSH Terms
- Anemia
- Antineoplastic Agents
- Neoplasms
- Multiple Myeloma
- Lymphoma
Contact
Organisation Name:
All Wales Medicines Strategy Group
Contact Address:
All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX
Contact Name:
AWTTC@wales.nhs.uk
Contact Email:
AWTTC@wales.nhs.uk
Copyright:
AWTTC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.